ABSTRACT
BACKGROUND: The occurrence of syphilis and HIV-1 infections during pregnancy are major risks to the fetus due to mother-to-child transmission (MTCT). OBJECTIVES: To determine peripartum seroprevalence and risk factors of syphilis and HIV-1 infection among pregnant women in Salvador, Brazil, and the rate of HIV-1 MTCT. METHODS:Cross-sectional study of pregnant women who were admitted for delivery in a reference maternity hospital between May 2008 and March 2009 was conducted. Women were screened for HIV-1 infection and syphilis, and interviewed regarding demographic, behavioral and obstetric data. Newborns to HIV-infected mothers were tested by b-DNA and DNA-PCR to detect HIV-1. RESULTS: A total 3300/8516 women were evaluated. Mean age was 25.8 ± 7.3 years. HIV-1 and syphilis seroprevalence rates were 0.84% (28/3300) and 0.51% (17/3300), respectively. HIV-1 infection was associated with: low education (p = 0.04), having a partner with known HIV infection (p < 0.0001) or with previous sexually transmitted infection (p < 0.0001), blood transfusion (p = 0.003), or accidental exposure to blood (p = 0.003). Syphilis was associated with being Caucasian (p = 0.02), having no steady partner (p = 0.02), being a housewife (p = 0.01), having an intravenous drug user (IVDU) sexual partner (p = 0.04) or a sexual partner with previous STI (p < 0.001). Higher education (p = 0.04) was protective against HIV-infection. Attending a prenatal care program was protective against syphilis (p = 0.008) and HIV-1 (p = 0.02). No case of HIV-1 MTCT was detected, but 25% of children born to HIV-infected mothers were lost to follow up. CONCLUSIONS: In Salvador, peripartum prevalence of syphilis and HIV-1 infection among pregnant women were low, and associated with classic risk factors for both infections. The great proportion of very late diagnosis of HIV infection, and the high rate of loss of follow-up among positive mothers and their infants are of high concern.
Subject(s)
Adult , Female , Humans , Infant, Newborn , Pregnancy , HIV Infections/epidemiology , Pregnancy Complications, Infectious/epidemiology , Syphilis/epidemiology , Brazil/epidemiology , Epidemiologic Methods , HIV Infections/diagnosis , Patient Dropouts/statistics & numerical data , Pregnancy Complications, Infectious/diagnosis , Socioeconomic Factors , Syphilis/diagnosisABSTRACT
Forty-nine AIDS patients, most of who were antiretroviral therapy (ARV) naïve, with active tuberculosis, were treated with Rifampin 600mg, Isoniazid 400mg and Pirazinamide 2g daily. They also received ARV, consisting of Efavirenz (600mg/day) plus 2 NRTIs. All patients were prospectively followed for at least 24 months. Baselines were: male/female ratio 2:1, mean age 34.7 ± 9.4 yrs; weight 51 ± 9.0 kg, viral load 5.6 ± 0.6 logs, CD4 cell count 101 ± 128 cells/ mm . Follow up mean values of data logs of VL and CD4+ cell /mm counts were: VL 1.7 and CD4+ 265; VL 1.3 and CD4+ 251; VL 1.4 and CD4+ 326 at 6, 12 and 24 months, respectively. Weight gain changes were: 5 ± 9.9 ± 12 and 21 ± 16 kg respectively at 6, 12 and 24 months. A non-concomitant ARV regimen was introduced at least three weeks after TB treatment initiation. Severe adverse reactions included rash (two), toxic hepatitis (six), Immune Reconstitution Syndrome (seven), and four deaths. We conclude that Efavirenz at a daily dose of 600 mg is sufficient and safe to treat HIV/TB patients using a Rifampin containing regimen.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Anti-HIV Agents , Antibiotics, Antitubercular , HIV Infections , Rifampin , Tuberculosis, Pulmonary , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , Cohort Studies , Drug Administration Schedule , Drug Interactions , Follow-Up Studies , Isoniazid , Prospective Studies , Pyrazinamide , Viral LoadABSTRACT
Immunotherapy has been proposed as a method to treat mucosal leishmaniosis for many years, but the approach has been hampered by poor definition and variability of antigens used, and results have been inconclusive. We report here a case of antimonial-refractory mucosal leishmaniasis in a 45 year old male who was treated with three single injections (one per month) with a cocktail of lour Leishmania recombinant antigens selected after documented hyporesponsiveness of the patient to these antigens, plus 50µg of GM-CSF as vaccine adjuvant. Three months after treatment, all lesions had resolved completely and the patient remains without relapse after two years. Side effects of the treatment included only moderate erythema and induration at the injection site after the second and third injections. We conclude that carefully selected microbial antigens and cytokine adjuvant can be sucessful as immunotherapy for patients with antimonial-refractory mucosal leishmaniasis.
Subject(s)
Humans , Male , Adult , Granulocyte-Macrophage Colony-Stimulating Factor , Immunotherapy , Leishmania , Leishmaniasis , Leishmaniasis, Mucocutaneous/therapy , Vaccines, Synthetic/immunology , Vaccines, Synthetic/therapeutic use , Amphotericin B , Antigens, Protozoan , Antimony , Brazil , Drug Tolerance , Immunization Schedule , PentamidineABSTRACT
De acordo com o cadastro de 1416 pacientes portadores de leishmaniose tegumentar americana (L.T.A) referentes ao período de janeiro de 1976 a maio de 1987, os autores realizaram um levantamento da procedência dos casos dessa parasitose atendidos nas áreas endêmicas de Três Braços e Corte de Pedra no estado da Bahia. Os pacientes procediam de 24 dos 89 municípios que compöem a regiäo cacaueira da Bahia, destacando-se os municípios de Valença, Wenceslau Guimaräes e Teolândia como os de maior prevalência, somando juntos 923 casos (65,1%, com 520 destes residindo em umas poucas localidades contínuas entre si, formando uma área endêmica, com transmissäo ocorrendo provavelmente no peri, intradomicílio e nas lavouras de cacau e cravo localizadas nas encostas da floresta atlântica. Nota-se que a partir de 1983, houve um aumento do número de casos em toda a regiäo, havendo evidências da leishmaniose tegumentar americana comportar-se como uma doença ocupacional em toda a regiäo estudada
Subject(s)
Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Humans , Male , Female , Leishmaniasis , Brazil , Cacao , Delivery of Health Care , Occupational Diseases , Leishmaniasis/epidemiology , Rural WorkersABSTRACT
Uma investigaçäo a respeito do que a populaçäo local pensa sobre vários aspectos da leishmaniose mucocutânea foi realizada em Três Braços, Bahia, uma área de alta prevalência de infecçäo por Leishmania braziliensis. Os resultados obtidos indicam que essa populaçäo tem um entendimento razoavelmente bom sobre alguns aspectos epidemiológicos e tratamento dessa doença, mas demonstram seu pouco conhecimento concernente à etiologia e prevençäo. Esses dados poderäo ser valiosos, no futuro, em um planejamento do controle de transmissäo da doença nesta comunidade